Aaron F. Barkoff
Contributor since: 2006
Latest Articles
District Court Delivers Good News to Mylan, Barr in Amrix Litigation
What's Next for Mylan After Court Dismisses Company's Complaint Against FDA?
Book Review: 'The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management'
AstraZeneca Defeats Teva's Unusual Patent Claim
Dr. Reddy's Wins Attorney Fees From AstraZeneca in Prilosec OTC Case
District Court Denies Teva's Motion to Stay Integrelin Case
Federal Circuit Vacates Injunction That Directed Novo Nordisk to Revise Patent Use Code for Prandin
Pharmas Walking the Patent Tightrope
Bayer Patent on Yasmin Affirmed Invalid
Supreme Court Denies Aventis' Cert Petition in Lovenox Case
Federal Circuit Affirms Extension of Stay Against Teva's Generic Evista
Federal Circuit Affirms Fee Award to Takeda
Federal Circuit Affirms Merck’s Victory in Trusopt/Cosopt Case
District Court Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis
KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied
Eisai Victorious Over Teva and Dr. Reddy’s in Aciphex Compound Patent Case
Merck Victorious over Apotex in Fosamax Counterclaims Case
Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
Roche and Allergan Victorious Over Apotex in Acular LS Dispute
Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
Teva Granted Final Approval of Risperidone ANDA; Launches with 180-Day Exclusivity
FDA Denies King Pharma's Citizen Petition on Altace; Approves Ramipril ANDAs
Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
King Pharmaceuticals Files Citizen Petition Relating to New Altace Patent
Apotex Sues FDA to Recover Its 180-Day Exclusivity on Generic Plavix
Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis Dismissed
Validity of Takeda's Prevacid Patents Upheld; Teva's Obviousness Arguments Rejected
Court Affirms Decision Protecting Ortho-McNeil's Topamax Against Mylan's Generic
Federal Circuit Rules in Favor of Forest in Dispute with Caraco over Lexapro
Eisai Wins Preliminary Injunction Against Teva's Generic Altheimer's Drug
Court Sides with Amgen in European-Produced EPO Dispute with Roche
Court Upholds P&G's Actonel Patent; Rejects Teva's Obviousness Arguments